Covenant Asset Management LLC acquired a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 37,909 shares of the company's stock, valued at approximately $3,350,000.
Several other institutional investors have also recently modified their holdings of the company. Transce3nd LLC acquired a new stake in shares of HealthEquity in the fourth quarter worth approximately $29,000. Versant Capital Management Inc acquired a new stake in shares of HealthEquity in the first quarter worth approximately $28,000. Larson Financial Group LLC boosted its stake in shares of HealthEquity by 1,366.0% in the first quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after acquiring an additional 642 shares during the last quarter. Huntington National Bank boosted its stake in shares of HealthEquity by 89.4% in the fourth quarter. Huntington National Bank now owns 767 shares of the company's stock worth $74,000 after acquiring an additional 362 shares during the last quarter. Finally, Whipplewood Advisors LLC boosted its stake in shares of HealthEquity by 5,060.0% in the first quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after acquiring an additional 759 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at HealthEquity
In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president directly owned 75,689 shares of the company's stock, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock valued at $32,705,007 in the last three months. 1.50% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of equities analysts have weighed in on HQY shares. Royal Bank Of Canada boosted their price objective on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. The Goldman Sachs Group boosted their price objective on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. KeyCorp lowered their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Raymond James Financial reissued a "strong-buy" rating and set a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, JMP Securities boosted their price objective on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $118.55.
Check Out Our Latest Stock Analysis on HealthEquity
HealthEquity Trading Up 0.6%
HQY traded up $0.61 during mid-day trading on Tuesday, hitting $97.69. 196,006 shares of the stock were exchanged, compared to its average volume of 868,304. The firm's fifty day moving average is $101.65 and its two-hundred day moving average is $98.49. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The company has a market cap of $8.45 billion, a PE ratio of 71.31, a PEG ratio of 1.51 and a beta of 0.49.
HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The company had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the prior year, the business earned $0.80 EPS. Equities analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.
HealthEquity Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.